Maria Rossing 

Chief Physician, Clinical Research Associate Professor, Centre of Diagnostic Investigation, Rigshospitalet

Email: Caroline.maria.rossing@regionh.dk

Maria Rossing is a Clinical Research Associate Professor specializing in genomic medicine. She is affiliated with the Centre of Diagnostic Investigation at Rigshospitalet and Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen.

Her research focuses on cancer biomarkers, hereditary bleeding disorders, and advanced diagnostic methodologies. She has contributed to the study of homologous recombination deficiency testing, molecular subtyping in breast cancer, and variant classification of breast cancer associated genetic variants. Rossing has also participated in national and international breast cancer studies within the DBCG and ENIGMA - consortia, as well as the newly DAHEAN aiming to improve diagnostics for hereditary bleeding disorders. Her work spans from fundamental cell-based research to the integration of genomic medicine, with a constant focus on diagnostics and expanding access to targeted treatments.

Steno Diabetes Center Copenhagen

Steno Diabetes Center Copenhagen is an internationally recognized center for diabetes care, research, prevention, and education. Its research activities encompass both clinical and translational research, as well as research in prevention, health promotion, and community-based care.

The Department of Clinical and Translational Research consists of six research groups focusing on clinical epidemiology, diabetes complications, diabetes technology, and translational research in both type 1 and type 2 diabetes, as well as cardiometabolic prevention. The overall objective is to translate scientific discoveries into improved prevention, diagnosis, and treatment of diabetes.

Research within prevention, health promotion, and community-based care aims to bridge the gap between research and real-world practice through interdisciplinary collaborations across healthcare systems, municipalities, research institutions, and civil society organizations, both nationally and internationally. The goal is to develop sustainable solutions that improve quality of life for people living with diabetes and reduce the burden of disease across populations.